Stocktoria
Pluri Inc. PLUR
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2007-12-10
Pluri Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 44.6% | 49.0% | 98.8% | 96.9% | 100.0% | — | 100.0% | 96.3% | 96.0% | — |
| Operating margin | -2454.5% | -1659.9% | -6796.9% | -9493.4% | -17774.8% | — | -128156.5% | -65800.0% | -67462.0% | — |
| Net margin | -2344.6% | -1690.3% | -6407.4% | -9867.9% | -17624.8% | — | -126747.8% | -65383.3% | -52252.0% | — |
| FCF margin | -1990.3% | -1484.2% | -5627.0% | -8055.4% | -15718.4% | — | -115821.7% | -54985.2% | -43444.0% | — |
| Return on assets | -95.8% | -58.4% | -52.8% | -55.8% | -60.6% | -53.3% | -44.5% | -112.8% | -67.1% | -74.1% |
| Return on equity | 103.4% | 330.1% | -385.7% | -185.1% | -128.1% | -87.3% | -52.0% | -161.8% | -91.6% | -91.9% |
| Current ratio | 0.27 | 0.68 | 6.98 | 7.37 | 8.46 | 5.85 | 6.07 | 3.23 | 3.75 | 5.36 |
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.